Support veterans during National Mentoring Month

January 21, 2022

  January is National Mentoring Month, and a great opportunity for UT Health San Antonio employees to support veterans and the Armed Forces. Through a partnership with American Corporate Partners (ACP), a national, non-profit organization, volunteers can help military service members transition to the private sector through one-on-one mentorship. The UT System is currently the only public university […]


Brief writing therapy effective as treatment for military members with PTSD, study shows

January 11, 2022

A brief, five-session treatment for post-traumatic stress disorder (PTSD) called Written Exposure Therapy is as effective as a longer, gold-standard treatment for military service members, a new study shows. In their paper published today by JAMA Network Open, researchers say the treatment option potentially can make effective PTSD treatment more appealing and accessible to military personnel […]




Brief writing therapy effective as treatment for military members with PTSD, study shows

January 11, 2022

Media contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 11, 2021) — A brief, five-session treatment for post-traumatic stress disorder (PTSD) called Written Exposure Therapy is as effective as a longer, gold-standard treatment for military service members, a new study shows. In their paper published today by JAMA Network Open, researchers say the treatment option potentially […]

PTSD



U.S. Medicine: Immunologic resistance used to predict COVID-19 outcomes in veterans

October 25, 2021

Dr. Grace Lee of the Pharmacotherapy Education and Research Center in the Long School of Medicine; Dr. Marcos Restrepo, Division of Pulmonary and Critical Care Medicine; and Dr. Sandra Sanchez-Reilly, Division of Geriatrics, Gerontology and Palliative Medicine, are quoted about their study of immunologic resilience measured in 522 VA patients. Read story


Brain injury therapy advancing toward human studies

October 8, 2021

Research that began at The University of Texas Health Science Center at San Antonio 15 years ago is nearing a significant milestone: human testing of an intravenous (IV) drug to treat brain injuries such as concussion and stroke.

Neuron concept art